Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.

2025

https://researcherprofiles.org/profile/679812113

40970353

Salazar-Camelo A, Vega L, Fadlallah Y, Bou Rjeily N, Balshi A, Morris B, Ghajarzadeh M, Mowry EM, Waubant E, Nourbakhsh B